IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.

IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.
复制标题

IL-10的髓样细胞免疫调节调节卵巢癌的鼠模型。

DOI:
10.3389/fimmu.2011.00029
复制
发表时间:
2011
影响因子:
7.3
通讯作者:
Berwin B
Berwin B
中科院分区:
医学2区
文献类型:
--
作者:
Hart KM;Byrne KT;Molloy MJ;Usherwood EM;Berwin B

文献摘要

参考文献

被引文献

相似文献

人卵巢癌微环境和卵巢癌小鼠模型中IL-10水平升高已得到充分证实,并与不良临床预后相关。然而,在众多的免疫抑制因子中,IL-10对卵巢肿瘤微环境的实际贡献、其作用机制及其可能的功能冗余尚不清楚。我们以前证明,消除卵巢肿瘤腹水中的髓源性抑制细胞(MDSC)隔室可抑制肿瘤进展,有趣的是,可显著降低局部IL-10水平。在这里,我们确定了一种新的途径,其中肿瘤浸润MDSC是IL-10的主要生产者,重要的是,需要它来发展其体内免疫抑制功能。重要的是,我们证明了IL-10的作用是至关重要的,而不是多余的其他免疫抑制分子,在体内肿瘤进展:IL-10信号网络的阻断导致减轻MDSC介导的免疫抑制,改变T细胞表型和活性,并提高生存。这些研究将IL-10定义为卵巢肿瘤微环境中MDSC和T细胞的基本调节剂。重要的是,IL-10信号传导被证明是发展和维持容许肿瘤微环境所必需的,并且代表了抗肿瘤策略的可行靶标。
Elevated levels of IL-10 in the microenvironment of human ovarian cancer and murine models of ovarian cancer are well established and correlate with poor clinical prognosis. However, amongst a myriad of immunosuppressive factors, the actual contribution of IL-10 to the ovarian tumor microenvironment, the mechanisms by which it acts, and its possible functional redundancy are unknown. We previously demonstrated that elimination of the myeloid-derived suppressor cell (MDSC) compartment within the ovarian tumor ascites inhibited tumor progression and, intriguingly, significantly decreased local IL-10 levels. Here we identify a novel pathway in which the tumor-infiltrating MDSC are the predominant producers of IL-10 and, importantly, require it to develop their immunosuppressive function in vivo. Importantly, we demonstrate that the role of IL-10 is critical, and not redundant with other immunosuppressive molecules, to in vivo tumor progression: blockade of the IL-10 signaling network results in alleviation of MDSC-mediated immunosuppression, altered T cell phenotype and activity, and improved survival. These studies define IL-10 as a fundamental modulator of both MDSC and T cells within the ovarian tumor microenvironment. Importantly, IL-10 signaling is shown to be necessary to the development and maintenance of a permissive tumor microenvironment and represents a viable target for anti-tumor strategies.
DOI: 10.4049/jimmunol.1000901
发表时间: 2010-08-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Lechner MG;Liebertz DJ;Epstein AL
通讯作者: Epstein AL
DOI: 10.1007/s002620100196
发表时间: 2001-08-01
影响因子: 5.8
作者:
Berger, S;Siegert, A;Hauptmann, S
通讯作者: Hauptmann, S
DOI: 10.1073/pnas.0503726102
发表时间: 2005-07-05
影响因子: 11.1
作者:
Klebanoff, CA;Gattinoni, L;Restifo, NP
通讯作者: Restifo, NP
DOI: 10.1593/neo.09228
发表时间: 2009-06-01
期刊: NEOPLASIA
影响因子: 4.8
作者:
Hart, Kevin M.;Bak, S. Peter;Berwin, Brent
通讯作者: Berwin, Brent
DOI: 10.1182/blood-2010-06-287839
发表时间: 2010-12-16
期刊: BLOOD
影响因子: 20.3
作者:
Highfill, Steven L.;Rodriguez, Paulo C.;Blazar, Bruce R.
通讯作者: Blazar, Bruce R.